|
1
|
Donato R: S100: A multigenic family of
calcium-modulated proteins of the EF-hand type with intracellular
and extracellular functional roles. Int J Biochem Cell Biol.
33:637–668. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shiras A, Bhosale A, Shepal V, Shukla R,
Baburao VS, Prabhakara K and Shastry P: A unique model system for
tumor progression in GBM comprising two developed human
neuro-epithelial cell lines with differential transforming
potential and coexpressing neuronal and glial markers. Neoplasia.
6:520–532. 2003. View Article : Google Scholar
|
|
3
|
Nash DL, Bellolio MF and Stead LG: S100 as
a marker of acute brain ischemia: A systematic review. Neurocrit
Care. 8:301–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dagdan E, Morris DW, Campbell M, Hill M,
Rothermundt M, Kästner F, Hohoff C, von Eiff C, Krakowitzky P, Gill
M, et al: Functional assessment of a promoter polymorphism in
S100B, a putative risk variant for bipolar disorder. Am J Med Genet
B Neuropsychiatr Genet. 156B:691–699. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Egberts F, Pollex A, Egberts JH, Kaehler
KC, Weichenthal M and Hauschild A: Long-term survival analysis in
metastatic melanoma: Serum S100B is an independent prognostic
marker and superior to LDH. Onkologie. 31:380–384. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weide B, Richter S, Büttner P, Leiter U,
Forschner A, Bauer J, Held L, Eigentler TK, Meier F and Garbe C:
Serum S100B, lactate dehydrogenase and brain metastasis are
prognostic factors in patients with distant melanoma metastasis and
systemic therapy. PLoS One. 8:e816242013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang XG, Meng Q, Qi FM and Yang QF:
Blocking TGF-β inhibits breast cancer cell invasiveness via
ERK/S100A4 signal. Eur Rev Med Pharmacol Sci. 18:3844–3853.
2014.PubMed/NCBI
|
|
9
|
Davydov DM, Lobanov AV, Morozov SG,
Gribova IE and Murashev AN: Neurodevelopment and
phenotype-modulating functions of S100B protein: A pilot study.
Physiol Behav. 140:188–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang XX, Li F, Hu WG, Xia HC and Zhang ZC:
Preparation and preliminary application of monoclonal antibodies
against Trichokirin-S1, a small ribosome-inactivating peptide from
the seeds of Trichosanthes kirilowii. Acta Biochim Biophys
Sin (Shanghai). 37:447–452. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vasconcellos FA, Aleixo PB, Stone SC,
Conceição FR, Dellagostin OA and Aleixo JA: Generation and
characterization of new HER2 monoclonal antibodies. Acta Histochem.
115:240–244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuasa N, Koyama T and Fujita-Yamaguchi Y:
Purification and refolding of anti-T-antigen single chain
antibodies (scFvs) expressed in Escherichia coli as
inclusion bodies. Biosci Trends. 8:24–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang D, Zhang J, Liu Z, Chen Y, Xu C,
Zhang Z, Liu X, Wu L, Zhou X, Meng X, et al: Functional expression,
characterization and application of the human S100A4 protein. Mol
Med Rep. 11:175–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bresnick AR, Weber DJ and Zimmer DB: S100
proteins in cancer. Nat Rev Cancer. 15:96–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Allore R, O'Hanlon D, Price R, Neilson K,
Willard HF, Cox DR, Marks A and Dunn RJ: Gene encoding the beta
subunit of S100 protein is on chromosome 21: Implications for Down
syndrome. Science. 239:1311–1313. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu J, Esposito G, Scuderi C, Steardo L,
Delli-Bovi LC, Hecht JL, Dickinson BC, Chang CJ, Mori T and Sheen
V: S100B and APP promote a gliocentric shift and impaired
neurogenesis in Down syndrome neural progenitors. PLoS One.
6:e221262011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poelmans G, Engelen JJ, Van Lent-Albrechts
J, Smeets HJ, Schoenmakers E, Franke B, Buitelaar JK,
Wuisman-Frerker M, Erens W, Steyaert J, et al: Identification of
novel dyslexia candidate genes through the analysis of a
chromosomal deletion. Am J Med Genet B Neuropsychiatr Genet.
150B:140–147. 2009. View Article : Google Scholar : PubMed/NCBI
|
